HIV

Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says
Fierce Pharma
Wed, 07/5/17 - 07:02 pm
Merck
GSK
HIV
ViiV
EFdA
Janssen gets EU nod for continuous manufacturing
BioPharma Dive
Fri, 06/30/17 - 09:45 am
Janssen
Europe
drug manufacturing
Prezista
HIV
FDA approves Teva's generic copy of Truvada
BioPharma Dive
Wed, 06/14/17 - 09:04 pm
FDA
Teva Pharmaceutical
generics
Truvada
HIV
Gilead Sciences
GSK uses priority voucher to file HIV combo
BioPharma Dive
Sat, 06/3/17 - 09:20 am
GSK
priority review
HIV
ViiV
ViiV, GSK gamble a surprise $130M chip in a high-stakes HIV playoff with Gilead
Endpoints
Thu, 06/1/17 - 11:56 pm
GSK
ViiV
HIV
Gilead racing to FDA with a new HIV cocktail boasting megablockbuster potential
Endpoints
Thu, 06/1/17 - 09:14 am
Gilead Sciences
FDA
HIV
FTC/TAF
Gilead needs to best Glaxo with bictegravir
EP Vantage
Thu, 05/18/17 - 12:14 am
Gilead Sciences
GSK
bictegravir
Dolutegravir
HIV
The Worst-Case Scenario for Gilead Sciences, Inc.
Motley Fool
Sat, 04/1/17 - 08:06 am
Gilead Sciences
M&A
hepatitis C
HIV
Here's Why the Best Is Yet to Come for Gilead Sciences, Inc.
Motley Fool
Tue, 03/7/17 - 11:17 am
Gilead Sciences
HIV
hepatitis C
Napo amps up sales force for AIDS anti-diarrheal
BioPharma Dive
Wed, 03/1/17 - 08:55 pm
Napo
drug reps
AIDS
HIV
Mytesi
Alamo Pharma Services
This Strategy Could Boost GILD’s HIV Franchise Revenue in 2017
Market Realist
Thu, 02/23/17 - 09:47 pm
Gilead Sciences
HIV
3 Things Gilead Sciences' CEO Just Said That You'll Want to Know
Motley Fool
Wed, 02/22/17 - 05:10 pm
Gilead Sciences
Pharma CEOs
John Milligan
hepatitis C
HIV
M&A
Merck’s HIV drug doravirine looks solid — though far less stellar than rivals — in 1st PhIII
Endpoints
Wed, 02/15/17 - 09:45 am
Merck
HIV
Doravirine
JNJ
Prezista
Gilead challenges GSK with strong HIV drug data
Yahoo/Reuters
Tue, 02/14/17 - 09:28 am
Gilead Sciences
GSK
HIV
bictegravir
Dolutegravir
Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Medical Marketing and Media
Thu, 02/9/17 - 11:16 am
Gilead Sciences
social media
Truvada
HIV
GlaxoSmithKline and Gilead to face off at HIV meeting next week
Yahoo/Reuters
Thu, 02/9/17 - 09:44 am
GSK
Gilead Sciences
HIV
bictegravir
Dolutegravir
Could Gilead Sciences' Game-Changing HIV Pill Solve Its Growth Problem?
Motley Fool
Tue, 12/20/16 - 12:11 pm
Gilead Sciences
HIV
Truvada
Switching course, Gilead markets HIV drug for prevention
Yahoo/Reuters
Thu, 12/1/16 - 10:28 am
Truvada
Gilead Sciences
HIV
Gilead Sciences' HCV Fall Was Partially Offset by HIV Business
Market Realist
Mon, 11/28/16 - 11:26 pm
Gilead Sciences
hepatitis C
HIV
CRISPR identifies genes that might be targeted to hobble HIV infection
Stat
Tue, 10/25/16 - 03:48 pm
CRISPR-Cas9
HIV
genome editing

Pages